Julie Holder Email

Head Preclinical Research . MitoRx Therapeutics

Oxford, Oxfordshire

Location

LinkedIn

Current Roles

Employees:
18
Revenue:
$1.4M
About
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
MitoRx Therapeutics Address
Rennes Drive
Oxford, Oxfordshire
MitoRx Therapeutics Email